MPC Therapeutics
Pre-clinicalMPC Therapeutics is a Swiss biotech developing a universal T cell supplement designed to enhance the fitness and persistence of cell therapies against cancer.
Founded
2019
Focus
OncologyCell TherapyImmunology
About
MPC Therapeutics is a Swiss biotech developing a universal T cell supplement designed to enhance the fitness and persistence of cell therapies against cancer.
Funding History
1Total raised: $12M
Series A$12MUndisclosedMay 15, 2021
Company Info
TypePrivate
Founded2019
LocationGeneva, Switzerland
StagePre-clinical
Contact
SIMILAR COMPANIES
3Brain
Pre-clinical · Zug
Baxiva
Pre-clinical · Zug
AC Bioscience
Pre-clinical · Lausanne
Abrinca Genomics
Pre-clinical · Zurich
AdipoGen
Pre-clinical · Liestal
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile